Bridgebio Oncology Therapeutics, Inc. (BBOT) SEC Filings — 2026
2 SEC filings for Bridgebio Oncology Therapeutics, Inc. (BBOT) in 2026.
Filings
- Bridgebio Oncology Therapeutics, Inc. EFFECT Filing — EFFECT · May 5, 2026
- BridgeBio Oncology Appoints New CMO, Dr. Morrissey — 8-K · Mar 26, 2026